The Evolving Role of Mohs Surgeons in Advancing Management of laBCC
Advertisement
Advertisement
Trending on Dermatology Times
1
Sanofi Discontinues Development of OX40L Inhibitor Amlitelimab in Atopic Dermatitis
2
SPD 2026: Clinical Considerations and Inclusive Communication in Pediatric Gender-Affirming Dermatology
3
Sunscreen’s New Blind Spot: Fashion Trends, Tanning Myths, and the Rise of Gluteal Melanomas
4
Switching from Biologics to Upadacitinib Yields Progressive Improvements in Moderate to Severe AD
5